Old Web
English
Sign In
Acemap
>
authorDetail
>
Jonathan Rubino
Jonathan Rubino
Institut Gustave Roussy
Population
Oncology
Temozolomide
Internal medicine
Topotecan
2
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
First-in-child phase I/II study of the dual mTORC1/2 inhibitor vistusertib (AZD2014) as monotherapy and in combination with topotecan-temozolomide in children with advanced malignancies: arms E and F of the AcSé-ESMART trial.
2021
European Journal of Cancer
Raphael J. Morscher
Caroline Brard
Pablo Berlanga
Lynley V. Marshall
Nicolas André
Jonathan Rubino
Isabelle Aerts
Emilie De Carli
Nadège Corradini
Souad Nebchi
Xavier Paoletti
Peter G. Mortimer
Ludovic Lacroix
Gaëlle Pierron
G Schleiermacher
Gilles Vassal
Birgit Geoerger
Show All
Source
Cite
Save
Citations (0)
Phase I or II Study of Ribociclib in Combination With Topotecan-Temozolomide or Everolimus in Children With Advanced Malignancies: Arms A and B of the AcSé-ESMART Trial.
2021
Journal of Clinical Oncology
Francisco Bautista
Xavier Paoletti
Jonathan Rubino
Caroline Brard
Keyvan Rezai
Souad Nebchi
Nicolas André
Isabelle Aerts
Emilie De Carli
Natasha K.A. van Eijkelenburg
Estelle Thebaud
Nadège Corradini
Anne Sophie Defachelles
Stéphane Ducassou
Raphael J. Morscher
Gilles Vassal
Birgit Geoerger
Show All
Source
Cite
Save
Citations (2)
1